Market Research Insights

  The global decision intelligence market size is expected to reach USD 53.21 billion by 2033, registering a CAGR of 14.4% from 2026 to 2033, according to a new report by Grand View Research, Inc. As businesses increasingly adopt artificial intelligence (AI) and machine learning (ML) technologies to gain a competitive edge, decision intelligence is emerging to connect decision support, decision management, and complex systems applications. In today's data-driven landscape, organizations face the challenge of navigating through vast amounts of information. This results in decision intelligence emerging as the vital solution, bridging the gap between data and improved decision-making. Industries, such as financial services, healthcare, and supply chain management, urgently need reliable decision-making capabilities. By harnessing the power of decision intelligence, these industries can fully leverage the potential of their data and effectively optimize the utilization of AI, empower...

  The global AI in pathology market size was estimated at USD 168.25 million in 2025 and is projected to reach USD 1,151.55 million by 2033, growing at a CAGR of 27.42% from 2026 to 2033. Growing demand for precision medicine, rising prevalence of chronic diseases, technological advancements are significant factors contributing to market growth. Moreover, the growing digitization of pathological infrastructure, supportive regulatory progress, and industry partnerships are strengthening the market environment. The growing demand for precision medicine is one of the significant drivers of artificial intelligence in pathology industry. AI facilitates tailored treatments by integrating histopathological image analysis with genomic data to provide more precise disease subtyping and prognosis. For instance, in July 2025, LG AI Research unveiled its upgraded pathology AI model, EXAONE Path 2.0, to enhance cancer diagnosis and drug development. The system combines analysis of both entire...

  The global ultrasound devices market size is expected to reach USD 16.4 billion by 2033, registering a CAGR of 4.66% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is expected to experience steady growth during the forecast period. This is attributed to several factors such as increased adoption of ultrasonography for diagnostic and therapeutic applications, rising technological advancements, as well an increase in the number of product launches by key players operating in the market. Emerging innovations in ultrasound technology are expanding the market size. Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities globally. Furthermore, the introduction of 3D/4D ultrasound and the integration of artificial intelligence (Al) to automate time-consuming processes are expected to propel market growth during the forecast period. For instance, in July 2023, Sonosite ST was introduced by FUJIFI...

  The global healthcare CRM market size was estimated at USD 21.5 billion in 2025 and is projected to reach USD 35.7 billion by 2033, growing at a CAGR of 6.2% from 2026 to 2033. The rising demand for structured data and automation in healthcare organizations is expected to drive market growth. Technological advancements, such as AI integration in CRM solutions, enhance effectiveness and drive widespread adoption, while the growing need to improve the customer experience is fueling the adoption of healthcare CRM solutions. Healthcare organizations are increasingly challenged by the growing complexity of patient access workflows, including scheduling, referrals, insurance verification, and prior authorizations. The expansion of care delivery across multi-site networks and virtual channels has made reliance on manual or fragmented systems inefficient, leading to access delays, administrative bottlenecks, and inconsistent patient experiences. Download a free sample copy of the Healt...

 The global self-expanding covered stents market size was estimated at USD 743.8 million in 2025 and is projected to reach USD 1,091.7 million by 2033 , growing at a CAGR of 5.0% from 2026 to 2033 . The increasing prevalence of peripheral artery disease and aortoiliac occlusive disease, rising incidence of Aneurysm, are driving the demand for effective vascular interventions, thereby boosting the adoption of self-expanding covered stents. The section below outlines the key factors driving the growth of the self-expanding covered stents (SX-CS) market, highlighting the rising prevalence of peripheral artery disease and aortoiliac occlusive disease, along with the increasing demand for minimally invasive vascular interventions. It also examines the role of technological advancements, such as Nitinol-based stent designs and improved Polytetrafluoroethylene coverings, as well as the expanding use of SX-CS in complex procedures, including Endovascular Aneurysm Repair, Fenestrated End...